We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Osi Pharmaceuticals Inc. (MM) | NASDAQ:OSIP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.49 | 0 | 01:00:00 |
Delaware
|
0-15190
|
13-3159796
|
||
(State
or other jurisdiction of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Exhibit No.
|
Description
|
99.1
|
Press
release
date
d March 19,
2010.
|
99.2
|
Press
release
date
d March 22,
2010.
|
Date:
March 24, 2010
|
OSI
PHARMACEUTICALS, INC.
|
|
By:
|
/s/ Barbara A. Wood
|
|
Barbara
A. Wood
|
||
Senior
Vice President, General Counsel and
Secretary
|
Exhibit No.
|
Description
|
99.1
|
Press release dated March 19,
2010.
|
99.2
|
Press release dated March 22,
2010.
|
1 Year Osi Pharmaceuticals Chart |
1 Month Osi Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions